カテゴリ： MarketLine, ロシア, 企業調査

OAO Gazprom：企業の戦略・SWOT・財務情報

◆英語タイトル：OAO Gazprom - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C1829
◆発行会社（調査会社）：MarketLine
◆発行日：2018年7月
◆ページ数：62
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ロシア
◆産業分野：石油・ガス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

OAO Gazprom – Strategy, SWOT and Corporate Finance Report
Summary

OAO Gazprom – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

OAO Gazprom (Gazprom or ‘the company’) is a global energy company engaged in the geological exploration, production, transportation, storage, processing and sales of gas, gas condensate and oil, sales of gas as a vehicle fuel as well as generation and marketing of heat and electric power. The company operates through eight segments: Distribution of Gas, Refining, Electric and Heat Energy Generation and Sales, Production of Crude Oil and Gas Condensate, Transportation, Production of Gas, Gas Storage, and All Other. Gazprom is headquartered in Moscow, Russia.

Scope

- Detailed information on OAO Gazprom required for business and competitor intelligence needs
- A study of the major internal and external factors affecting OAO Gazprom in the form of a SWOT analysis
- An in-depth view of the business model of OAO Gazprom including a breakdown and examination of key business segments
- Intelligence on OAO Gazprom’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about OAO Gazprom, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of OAO Gazprom and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess OAO Gazprom as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on OAO Gazprom’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
OAO Gazprom: Company Overview 9
OAO Gazprom: Overview and Key Facts 9
OAO Gazprom: Overview 9
OAO Gazprom: Key Facts 9
OAO Gazprom: Key Employees 11
OAO Gazprom: Key Employee Biographies 13
OAO Gazprom: Major Products and Services 15
OAO Gazprom: Company History 16
OAO Gazprom: Management Statement 32
OAO Gazprom: Locations and Subsidiaries 35
OAO Gazprom: Key Competitors 36
OAO Gazprom: Company Analysis 37
OAO Gazprom: Business Description 37
OAO Gazprom: SWOT Analysis 40
OAO Gazprom: SWOT Overview 40
OAO Gazprom: Strengths 40
OAO Gazprom: Weaknesses 41
OAO Gazprom: Opportunities 41
OAO Gazprom: Threats 42
OAO Gazprom: Corporate Financial Deals Activity 44
OAO Gazprom: Financial Deals Overview 44
OAO Gazprom: Targets and Partners 46
OAO Gazprom: Top Deals 2014 – 2018YTD* 47
OAO Gazprom: Advisors 48
OAO Gazprom: Top Financial Advisors 48
OAO Gazprom: Mergers and Acquisitions 49
OAO Gazprom: Capital Raising 50
OAO Gazprom: Partnership 51
OAO Gazprom: Divestments 52
OAO Gazprom: Recent Developments 53
OAO Gazprom: News and Events Summary 53
OAO Gazprom: Regulatory and Legal Events 56
OAO Gazprom: Strategy and Operations 58
Appendix 60
Contact Us 60
Methodology 60
About MarketLine 61

List of Tables
Table 1: OAO Gazprom: Key Facts
Table 2: OAO Gazprom: Key Employees
Table 3: OAO Gazprom: Locations and Subsidiaries
Table 4: OAO Gazprom: Key Competitors
Table 5: OAO Gazprom: Deal Activity by Deal Type - Volume (TTM*)
Table 6: OAO Gazprom: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: OAO Gazprom: Targets and Partners
Table 8: OAO Gazprom: Top Deals 2014 - 2018YTD*
Table 9: OAO Gazprom: Financial Advisor Ranking by Value (US$m)
Table 10: OAO Gazprom: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: OAO Gazprom: M&A Activity by Geography (2014 - YTD*2018)
Table 12: OAO Gazprom: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 13: OAO Gazprom: Capital Raising by Deal Type (2014 - YTD*2018)
Table 14: OAO Gazprom: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 15: OAO Gazprom: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 16: OAO Gazprom: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 17: OAO Gazprom: Divestments by Geography (2014 - YTD*2018)
Table 18: OAO Gazprom: News and Events Summary
Table 19: OAO Gazprom: Regulatory and Legal Events
Table 20: OAO Gazprom: Strategy and Operations

List of Figures
Figure 1: OAO Gazprom: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: OAO Gazprom: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: OAO Gazprom: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: OAO Gazprom: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: OAO Gazprom: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 6: OAO Gazprom: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 7: OAO Gazprom: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 8: OAO Gazprom: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 9: OAO Gazprom: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 10: OAO Gazprom: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[OAO Gazprom：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • CEL-SCI Corp (CVM)-製薬・医療分野：企業M&A・提携分析
    Summary CEL-SCI Corp (CEL-SCI) is a biotechnology company that carries out the research and development of new immunotherapy products for the treatment of various cancer and infectious diseases. Its core capabilities include drug discovery, research, development and manufacturing of compound biologi …
  • Sasol Limited：企業の戦略・SWOT・財務分析
    Sasol Limited - Strategy, SWOT and Corporate Finance Report Summary Sasol Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Myriad Group AG：企業の戦略的SWOT分析
    Myriad Group AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • M.C. Dean, Inc.：戦略・SWOT・企業財務分析
    M.C. Dean, Inc. - Strategy, SWOT and Corporate Finance Report Summary M.C. Dean, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Alliancebernstein Holding Lp：企業の戦略・SWOT・財務分析
    Alliancebernstein Holding Lp - Strategy, SWOT and Corporate Finance Report Summary Alliancebernstein Holding Lp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Epic Pharma LLC：製薬・医療：M&Aディール及び事業提携情報
    Summary Epic Pharma LLC (Epic Pharma), a subsidiary of Humanwell Healthcare (Group) Co Ltd is a drug development company that manufactures and develops generic prescription drugs. The company’s products include amlodipine besylate, citalopram, betaxolol, nicardipine hydrochloride, guanfacine hydroch …
  • CEL-SCI Corp (CVM)：企業の財務・戦略的SWOT分析
    CEL-SCI Corp (CVM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • AstraZeneca Plc (AZN)：医療機器：M&Aディール及び事業提携情報
    Summary AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory; cardiovascular and renal and metabolic diseases; and cancer, besides autoimmune, infection a …
  • Xtract Resources Plc (XTR)：企業の財務・戦略的SWOT分析
    Summary Xtract Resources Plc (Xtract Resources), formerly Xtract Energy plc is a mining and mineral exploration and development company that offers mineral resources. The company acquires, explores, manages, operates, produces, mines, extracts, and develops gold and mineral resource deposit properti …
  • Reliance Infrastructure Ltd.：企業の戦略・SWOT・財務分析
    Reliance Infrastructure Ltd. - Strategy, SWOT and Corporate Finance Report Summary Reliance Infrastructure Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Phoenix Global Resources Plc (PGR)：石油・ガス：M&Aディール及び事業提携情報
    Summary Phoenix Global Resources Plc (Phoenix), formerly known as Andes Energia Plc, is an upstream oil and gas company. It conducts exploration, development and production of oil and gas for conventional and unconventional resources. It has diversified portfolio of oil and gas assets in Argentina. …
  • TAXIS Pharmaceuticals Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary TAXIS Pharmaceuticals Inc (TAXIS Pharma) is a biopharmaceutical company that treats, reduce and eliminates the threat of current and emergent antimicrobial resistance across a range of infectious diseases. It research new classes of antibiotic agents to treat life-threatening and multidrug-r …
  • Noble Mineral Exploration Inc (NOB)：企業の財務・戦略的SWOT分析
    Summary Noble Mineral Exploration Inc (Noble Mineral) is a mining and mineral exploration and development company that offers mineral resources. The company offers acquisition, exploration mining, production, and development of gold, nickel, copper, zinc, uranium, and mineral resources deposit prope …
  • Matrix Service Co：企業の戦略・SWOT・財務分析
    Matrix Service Co - Strategy, SWOT and Corporate Finance Report Summary Matrix Service Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Canadian Zeolite Corp.：企業の戦略・SWOT・財務情報
    Canadian Zeolite Corp. - Strategy, SWOT and Corporate Finance Report Summary Canadian Zeolite Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Porsche Automobil Holding SE (PAH3)：企業の財務・戦略的SWOT分析
    Porsche Automobil Holding SE (PAH3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Wolters Kluwer nv：企業の戦略・SWOT・財務分析
    Wolters Kluwer nv - Strategy, SWOT and Corporate Finance Report Summary Wolters Kluwer nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Keepmoat Ltd：企業の戦略的SWOT分析
    Keepmoat Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • National Railroad Passenger Corporation：企業の戦略・SWOT・財務情報
    National Railroad Passenger Corporation - Strategy, SWOT and Corporate Finance Report Summary National Railroad Passenger Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Nexgenia Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Nexgenia Inc (Nexgenia) is a developer and manufacturer of proprietary polymer-based reagents. The company offers stimuli-responsive polymers and polymer-containing magnetic nanoparticles that develops speed, efficiency and sensitivity of molecular and cell separations for diagnostic and lif …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆